Kenvue Urges FDA to Reject Request for Autism Warning on Tylenol

Dow Jones – HealthMonday, October 20, 2025 at 5:23:00 PM
NegativeHealth
Kenvue Urges FDA to Reject Request for Autism Warning on Tylenol
Kenvue is pushing back against a proposal to add warnings about the potential autism risks associated with Tylenol use during pregnancy, a concern raised by the Trump Administration. This matter is significant as it touches on public health and the safety of widely used medications, especially for expectant mothers.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
How Testosterone Is Giving Middle-Aged Women the Best Sex of Their Lives
PositiveHealth
A growing trend is emerging as middle-aged women are discovering the benefits of testosterone for enhancing their sexual experiences. Despite the lack of FDA-approved products and insurance coverage, many are turning to this hormone to reclaim their vitality and intimacy. This cultural phenomenon highlights the need for more awareness and acceptance of women's health issues, particularly in the realm of sexual wellness.
Roche Receives FDA Approval for Kidney Inflammation Drug
PositiveHealth
Roche has received FDA approval for a groundbreaking drug that treats kidney inflammation caused by lupus nephritis. This is significant because it is the only medication proven to help patients regain full kidney function, offering hope to many who suffer from this challenging condition.
Latest from Health
How Testosterone Is Giving Middle-Aged Women the Best Sex of Their Lives
PositiveHealth
A growing number of middle-aged women are discovering the benefits of testosterone, leading to improved sexual experiences despite the lack of FDA-approved products and insurance coverage. This trend highlights a cultural shift as women seek solutions for their sexual health, challenging traditional norms and sparking conversations about women's wellness.
Immigrant rights group calls for removing pregnant women from detention
PositiveHealth
An immigrant rights group is advocating for the release of pregnant women from U.S. detention facilities, highlighting concerns over inadequate medical care. This call to action is significant as it addresses the health and well-being of vulnerable populations, urging the government to reconsider its policies regarding expectant mothers in custody.
Mother of Baby P begins latest bid for release
NeutralHealth
Tracey Connolly, the mother of the tragic Baby P, is making another attempt to secure her release from prison, where she has been since 2009 following the death of her son, Peter. This case continues to resonate in the UK, highlighting ongoing discussions about child protection and the justice system's handling of such sensitive cases.
Parents angry as major maternity review scaled back
NegativeHealth
Parents are expressing their anger and disappointment as the NHS has decided to scale back a major maternity review, leaving out trusts in Shropshire and Leeds. This decision has raised concerns among families who feel that their voices are not being heard in a critical area of healthcare. The review was expected to address significant issues in maternity services, and its reduction could impact the quality of care for expectant mothers and their babies.
Staff skipped checks and said a vulnerable young woman was safe. Days later, she was dead
NegativeHealth
The tragic case of Cerys Lupton-Jones highlights serious failures in mental health care, as a coroner described the treatment she received as a 'shambles.' This incident raises critical questions about the safety protocols in place for vulnerable individuals and the accountability of care providers. It serves as a stark reminder of the urgent need for reform in mental health services to prevent such tragedies from occurring in the future.
New AI Tool Can Predict Breast Cancer Risk
PositiveHealth
A groundbreaking AI tool named Clairity Breast is revolutionizing breast cancer risk assessment by analyzing standard mammograms. This innovative model has shown to be about 30% more accurate than traditional methods that depend on personal and family health histories. This advancement is significant as it could lead to earlier detection and better outcomes for women at risk, making a real difference in healthcare.